136 related articles for article (PubMed ID: 9827928)
1. Human myeloma cell apoptosis induced by interferon-alpha.
Otsuki T; Yamada O; Sakaguchi H; Tomokuni A; Wada H; Yawata Y; Ueki A
Br J Haematol; 1998 Nov; 103(2):518-29. PubMed ID: 9827928
[TBL] [Abstract][Full Text] [Related]
2. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines.
Spets H; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
Blood; 1998 Oct; 92(8):2914-23. PubMed ID: 9763578
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2.
Egle A; Villunger A; Kos M; Böck G; Gruber J; Auer B; Greil R
Eur J Immunol; 1996 Dec; 26(12):3119-26. PubMed ID: 8977313
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 sensitizes multiple myeloma cell lines for apoptosis induced by interferon-alpha.
Minami R; Muta K; Ilseung C; Abe Y; Nishimura J; Nawata H
Exp Hematol; 2000 Mar; 28(3):244-55. PubMed ID: 10720689
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosis.
Liu P; Oken M; Van Ness B
Leukemia; 1999 Mar; 13(3):473-80. PubMed ID: 10086739
[TBL] [Abstract][Full Text] [Related]
6. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B
J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108
[TBL] [Abstract][Full Text] [Related]
7. Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression.
Jelinek DF; Aagaard-Tillery KM; Arendt BK; Arora T; Tschumper RC; Westendorf JJ
J Clin Invest; 1997 Feb; 99(3):447-56. PubMed ID: 9022078
[TBL] [Abstract][Full Text] [Related]
8. Upregulated production of IL-6, but not IL-10, by interferon-alpha induces SOCS3 expression and attenuates STAT1 phosphorylation in myeloma cells.
Usui E; Nishii K; Katayama N; Lorenzo V F; Chen F; Monma F; Otsuki T; Shiku H
Hematol J; 2004; 5(6):505-12. PubMed ID: 15570293
[TBL] [Abstract][Full Text] [Related]
9. Recombinant interferon-gamma inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro.
Jernberg-Wiklund H; Pettersson M; Nilsson K
Eur J Haematol; 1991 Apr; 46(4):231-9. PubMed ID: 1826658
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells.
Xu D; Erickson S; Szeps M; Gruber A; Sangfelt O; Einhorn S; Pisa P; Grandér D
Blood; 2000 Dec; 96(13):4313-8. PubMed ID: 11110707
[TBL] [Abstract][Full Text] [Related]
11. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF
J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587
[TBL] [Abstract][Full Text] [Related]
12. Effects of interferon alpha on myeloma cells: mechanisms of differential responsiveness.
Jelinek DF; Arora T
Curr Top Microbiol Immunol; 1997; 224():261-8. PubMed ID: 9308250
[No Abstract] [Full Text] [Related]
13. G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells.
Cheriyath V; Glaser KB; Waring JF; Baz R; Hussein MA; Borden EC
J Clin Invest; 2007 Oct; 117(10):3107-17. PubMed ID: 17823654
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 10 abolishes the growth inhibitory effects of all-trans retinoic acid on human myeloma cells.
Otsuki T; Yata K; Sakaguchi H; Kurebayashi J; Matsuo Y; Uno M; Fujii T; Eda S; Isozaki Y; Yawata Y; Yamada O; Wada H; Sugihara T; Ueki A
Br J Haematol; 2002 Mar; 116(4):787-95. PubMed ID: 11886382
[TBL] [Abstract][Full Text] [Related]
15. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P
Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha.
Shiratsuchi M; Muta K; Umemura T; Nishimura J; Nawata H; Kozuru M
Leuk Lymphoma; 1999 Jul; 34(3-4):349-59. PubMed ID: 10439372
[TBL] [Abstract][Full Text] [Related]
18. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.
Shima Y; Nishimoto N; Ogata A; Fujii Y; Yoshizaki K; Kishimoto T
Blood; 1995 Feb; 85(3):757-64. PubMed ID: 7530506
[TBL] [Abstract][Full Text] [Related]
19. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis.
Ferlin-Bezombes M; Jourdan M; Liautard J; Brochier J; Rossi JF; Klein B
J Immunol; 1998 Sep; 161(6):2692-9. PubMed ID: 9743325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
